Premium
Renal grafts from anti‐hepatitis B core‐positive donors: a quantitative review of the literature
Author(s) -
Mahboobi N.,
Tabatabaei S.V.,
Blum H.E.,
Alavian S.M.
Publication year - 2012
Publication title -
transplant infectious disease
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.69
H-Index - 67
eISSN - 1399-3062
pISSN - 1398-2273
DOI - 10.1111/j.1399-3062.2012.00782.x
Subject(s) - medicine , seroconversion , hepatitis b virus , hepatitis b , transplantation , transmission (telecommunications) , gastroenterology , hbsag , kidney transplantation , antibody , immunology , virus , electrical engineering , engineering
Backgrounds and aims Organ shortage is a major problem in transplantation. The use of organs from hepatitis B surface antigen ( HB sAg)‐negative and hepatitis B core antibody ( HB cAb)‐positive donors could significantly increase the donor pool. However, little information is available about the impact of HB cAb status of renal donors on viral transmission to recipients. To address this issue, the present quantitative review of relevant studies has been performed. Materials and methods Electronic databases including Medline, EMBASE , ISI , and Scopus were systematically searched for studies that evaluated risk of hepatitis B virus ( HBV ) transmission through renal transplantation from HB sAg‐/ HB cAb+ donors. Eligible studies were identified according to predefined criteria. The final outcome was one of HBV markers seroconversion defined as HB sAg, hepatitis B surface antibody ( HB sAb), or HB cAb detection in previously seronegative end‐stage renal disease ( ESRD ) patients after transplantation, and without other identified major sources of infection. Results Nine studies with 1385 eligible kidney recipients were included. In total, 45 subjects showed seroconversion of HBV markers as follows: HB sAg ( n = 4) (0.28%; 95% confidence interval [ CI ] 0.006; 0.57), HB cAb ( n = 32), HB sAb ( n = 5), and either HB cAb or HB sAb ( n = 4). The total rate of seroconversion after renal transplantation was calculated to be 3.24% (95% CI : 2.31–4.18). Conclusion Our review indicates that the risk of HBV transmission from HB cAb‐positive kidney donors is extremely low. Therefore, kidneys from these donors can be transplanted safely into ESRD patients.